No Data
No Data
Hunan Dajiaweikang Pharmaceutical Industry: 2024 Interim Performance Forecast
As of July 10th, 2024, Vicom Ltd (301126.SZ) had 15,793 shareholders.
On July 11th, Gelonhui reported that as of July 10th, 2024, the number of shareholders of Vicom Ltd. (301126.SZ) was 15,793 on the investor interactive platform.
Vicom Ltd (301126.SZ): The business of the pharmaceutical industry mainly focuses on the layout of Chinese patent medicine products, conducting the production and processing of pharmaceuticals, medical devices, food, and pharmaceutical research and develo
On June 19th, Gelonhui reported that Vicom Ltd. (301126.SZ) stated on the investor interaction platform that the company owns two pharmaceutical companies, Dajia Biopharmaceutical and Tianji Caotang, to build the company's pharmaceutical industry system. Currently, the company's pharmaceutical industry business mainly focuses on the layout of Chinese patent medicine products, conducts production and processing of pharmaceuticals, medical devices, food and other drugs research and development. The company's research product, Oseltamivir phosphate oral syrup, has completed CDE filing, and the clinical BE trial of atorvastatin calcium tablets is ongoing.
Vicom Ltd. (301126.SZ) specific shareholder, Qi Investment, and its concerted actors have jointly reduced their shareholding by 100,000 shares.
Vicom Ltd (301126.SZ) announced that specific shareholder Ningbo Meishan Free Trade Port Area Liangji Private Equity Investment Partnership Enterprise (Limited Partnership) ('Liangji Investment') and its concerted person Ningbo Meishan Free Trade Port Area Chunkang Equity Investment Partnership Enterprise (Limited Partnership) ('Chunkang Investment', together with 'Liangji Investment' referred to as 'this unit') have fulfilled their shareholding reduction plan. The above shareholders have reduced a total of 100,000 shares, with a reduction ratio of 0.04853%.
Vicom Ltd (301126.SZ): Bought back 427,500 shares for a total of 3,998,900 yuan for the first time.
On June 4th, 2024, Vicom Ltd. (301126.SZ) announced that it had repurchased 427,500 shares of the company's stock through a share buyback special securities account through centralized bidding, accounting for 0.21% of the total current share capital of the company, with a highest fill price of 9.76 yuan/share and a lowest fill price of 9.13 yuan/share. The total amount of funds used was RMB 3,998,949.00 (excluding transaction commissions and other fees).
Dajia Weikang (301126.SZ) plans to pay 0.4 yuan for every 10 shares in 2023, excluding interest on May 29
According to Zhitong Finance App, Dajia Weikang (301126.SZ) announced that in 2023, the company plans to distribute a cash dividend of RMB 0.40 (tax included) to all shareholders for every 10 shares. The share registration date for this equity distribution is May 28, 2024, and the ex-dividend date is May 29, 2024.
No Data